# MOCK SHELL: Table 14-4.02

## Adverse Events by System Organ Class and Preferred Term

---

**Protocol:** CDISCPILOT01
**Population:** Safety

---

**Treatment-Emergent Adverse Events occurring in â‰¥5% of subjects in any treatment group**

| System Organ Class | Placebo | Xanomeline Low Dose | Xanomeline High Dose |
|--------------------|---------|---------------------|----------------------|
| Preferred Term | (N=nnn) | (N=nnn) | (N=nnn) |
|---|---------|---------------------|----------------------|
| **CARDIAC DISORDERS** | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Palpitations | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| | | | |
| **EYE DISORDERS** | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| | | | |
| **GASTROINTESTINAL DISORDERS** | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Nausea | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Vomiting | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Diarrhoea | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| | | | |
| **GENERAL DISORDERS** | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Application site pruritus | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Application site erythema | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Fatigue | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| | | | |
| **INFECTIONS AND INFESTATIONS** | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Nasopharyngitis | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Upper respiratory tract infection | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| | | | |
| **NERVOUS SYSTEM DISORDERS** | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Dizziness | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Headache | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| | | | |
| **PSYCHIATRIC DISORDERS** | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| | | | |
| **RESPIRATORY DISORDERS** | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| | | | |
| **SKIN AND SUBCUTANEOUS DISORDERS** | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Rash | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Pruritus | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| | | | |
| **VASCULAR DISORDERS** | nn (xx.x) | nn (xx.x) | nn (xx.x) |
| Hypertension | nn (xx.x) | nn (xx.x) | nn (xx.x) |

---

**Notes:**
- N = Number of subjects in the Safety population
- n = Number of subjects with the specified event
- (%) = Percentage of subjects with the specified event
- A subject with multiple occurrences of an event is counted only once.
- System Organ Classes and Preferred Terms are coded using MedDRA Version X.X.
- Table sorted by System Organ Class frequency in Total column.
- Preferred Terms within each System Organ Class sorted by frequency in Total column.

**Program:** tlf-ae-soc-pt.R
**Source:** ADAE, ADSL

---

*Mock Shell Template - For specification purposes only*
